Michel Cherel - Publications

"Tumor Targeting, Imaging, RadiotherapieS" 17th edition of the workshop organized by the Cancéropôle Grand-Ouest, October 9-12, 2024, Erquy, France

Journal: Bulletin du cancer

Published: December 10, 2025

Temporal footprint reduction via neural network denoising in 177Lu radioligand therapy.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: April 11, 2025

Synthesis and 64Cu-Radiolabeling Strategies of Small Organic Radioconjugates Based on the AMD070 Scaffold.

Journal: ChemMedChem

Published: March 27, 2025

Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [211At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care.

Journal: Cancers

Published: February 10, 2025

Current landscape and future directions of targeted-alpha-therapy for glioblastoma treatment.

Journal: Theranostics

Published: October 30, 2024

"Optimizing Imaging and Dose-Response in Radiotherapies" XVIth workshop organised by the Cancéropôle Grand-Ouest's "Vectorisation, Imagerie, Radiothérapies" network - 4-7 October 2023, Erquy, France

Journal: Bulletin du cancer

Published: September 18, 2024

Grafting a chromophore on AMD070 analogues for CXCR4 bioimaging: Chemical synthesis and in vitro assessment of the inhibition properties of the CXCR4 receptor.

Journal: Bioorganic & medicinal chemistry letters

Published: May 17, 2024

Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 23, 2024

Junctional adhesion molecule C limits glioblastoma stem-like cell invasion by regulating integrin adhesion at the endothelial interface.

Journal: Cell reports

Published: March 04, 2024

Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice.

Journal: EBioMedicine

Published: February 14, 2024

Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies.

Journal: EJNMMI research

Published: July 10, 2023

Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma.

Journal: Pharmaceutics

Published: May 05, 2023